IOBT
Io Biotech, Inc. · HEALTHCARE
No insider bought or sold Io Biotech, Inc. in the last 12 months
$0Bought, 12 mo
$0Sold, 12 mo
IOBT over the last year
IOBT after insider buys
3 months after each buy, from the first price a copier could get.
−23.4%Average
−22.0 ptsVs S&P 500
2 of 6Higher
6 buys since 2021 with 3 months of prices.
Every filing
14 insider filings since 2021, newest first
IOBTBuy
Qasim Iftikhar Ahmad · Chief Medical Officer
$27KDec 26
IOBTSell
Novo Holdings A/s · 10% owner
$99K−2.0%Jul 26
IOBTSell
Novo Holdings A/S · 10% owner
$802K−13.0%May 14
IOBTSell
Novo Holdings A/s · 10% owner
$988K−11.0%Feb 13
IOBTBuy
Novo Holdings A/s · 10% owner
$5.0M+76.0%Aug 11
IOBTBuy
Vivo Capital Ix, LLC · 10% owner
$6.0M+105.0%Aug 10
IOBTBuy
Amy Sullivan · CFO
$58KMar 20
IOBTBuy
Hbm Healthcare Investments (Cayman) Ltd. · 10% owner
$4.5M+14.0%Nov 12
IOBTBuy
Vanessa Malier · Director
$4.5M+308.0%Nov 12
IOBTBuy
Vivo Capital Ix, LLC · 10% owner
$9.1M+27.0%Nov 12
IOBTBuy
Claus A. Andersson · Director
$1.1M+4.0%Nov 12
IOBTBuy
Invest A/s Lundbeckfond · 10% owner
$30.0M+55.0%Nov 12
IOBTBuy
Jack Nielsen · Director
$9.1M+27.0%Nov 12
IOBTBuy
Novo Holdings A/s · 10% owner
$4.5M+11.0%Nov 10
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.